
Retinopathy of Prematurity
Three-year FIREFLEYE outcomes reported for aflibercept vs laser in ROP
Children treated with intravitreal aflibercept 0.4 mg for retinopathy of prematurity (ROP) maintained stable disease control and age-appropriate visual function through 3...
Study highlights link between obesity indicators and risk of retinopathy
Multiple obesity indicators are significantly associated with an increased risk of retinopathy, with the weight-adjusted waist index (WWI) showing the strongest predictive...
Declining trends in retinopathy of prematurity screening eligibility among U.S. infants
A recent national study analyzed trends in retinopathy of prematurity (ROP) screening eligibility among U.S. infants from 2003 to 2022, revealing a...
Postnatal steroids in preterm infants associated with severity of retinopathy of prematurity
Cumulative dose and duration of postnatal steroid use are independently associated with the severity of retinopathy of prematurity (ROP) and the development of peripheral avascular retina (PAR) in preterm infants,...
Newly designed ROP educational materials improve parent understanding, follow-up compliance
Educational material on retinopathy of prematurity (ROP), which adhere to health literacy guidelines, has a significant impact on improving parent understanding of ROP, the perceived importance of follow-up care, and...
Nailfold capillaroscopy shows promise in predicting ROP in premature infants
Assessing nailfold microvascular density during the first month of life could serve as a promising non-invasive biomarker for identifying premature infants at the highest risk of developing retinopathy of prematurity...
Number of laser shots applied affects myopic status in retinopathy of prematurity
Axial length (AL), corneal refraction (CR), and crystalline lens power (CLP) are related to the degree of myopia in laser-treated retinopathy of prematurity (ROP) eyes, according to a study, which...
Retinopathy of prematurity incidence almost doubled over the past 20 years
From 2003 to 2019, the incidence of retinopathy of prematurity (ROP) among premature infants increased, suggesting a growing problem in the United States, according to an article. Traditionally underserved populations...
Non-contact widefield retinal imaging helps diagnosis, grading of ROP
A non-contact wide field retinal imaging (NC-WFI) system that utilizes true color images can be used for more accurate diagnosis and severity grading in patients with retinopathy of prematurity (ROP),...
FDA grants priority review for aflibercept in ROP
The U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept (Eylea; Regeneron) injection to treat retinopathy of prematurity (ROP) in preterm... ...
High bilirubin levels in neonates may protect against retinopathy of prematurity
Higher levels of bilirubin in preterm neonates may help protect against retinopathy of prematurity (ROP), with increased levels linked to reduced disease severity, according to a study. Researchers suggested that...